Home Article LiViliti Health Products receives FDA clearance for CPAP sanitizer

LiViliti Health Products receives FDA clearance for CPAP sanitizer

LiViliti Health Products receives FDA clearance for CPAP sanitizer

Also Noted

Default Author Head Shot

By HME News Staff

Updated 9:45 AM CDT, Mon May 4, 2026

SARASOTA, Fla. – LiViliti Health Products has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Paptizer 360. Classified as a Class II Respiratory Accessory Microbial Reduction Device, the Paptizer 360 provides a supplemental, at-home bacterial reduction process on compatible CPAP equipment. "This clearance marks a significant milestone for LiViliti as we continue to provide users with scientifically validated tools for their respiratory health," said Brian Sharpe, CEO of LiViliti Health Products. "The Paptizer 360 offers a fast, effective, and ozone-free way to supplement daily cleaning routines." LiViliti Health Products received an equity investment from Trace Medical last year. The two companies said they would coordinate a go-to-market initiative beginning in early 2026. LiViliti Health Products specializes in accessories and maintenance solutions for CPAP users.

Comments

To comment on this post, please log in to your account or set up an account now.